Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The L1 protein is the major capsid protein of Human papillomavirus type 16 (HPV16). It plays a central role in forming the viral capsid and in mediating infection. Recombinant expression of HPV16 L1 leads to spontaneous assembly into virus-like particles (VLPs) that closely mimic native virions but lack infectious DNA. These VLPs are highly immunogenic and form the basis for current prophylactic HPV vaccines.
L1 proteins self-assemble into virus-like particles (VLPs) that elicit a strong neutralizing antibody response, preventing HPV infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus L1 Capsid Protein Type 16 (HPV16 L1).